Brazil vs Greece: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and over time
- Brazil
- Greece
How they compare
Brazil currently reports 17.3% against 16.4% in Greece, a difference of 0.9%.
That makes Brazil's figure about 1.1 times Greece's.
Across all 22 years both countries report, Brazil has been ahead every year.
Brazil ranks 124th and Greece ranks 127th of 185 countries.
Brazil has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brazil | Greece | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 22.8% | 19.0% | 3.7% | Brazil |
| 2010s | 19.5% | 17.3% | 2.2% | Brazil |
| 2020s | 17.5% | 16.4% | 1.1% | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mortality from cvd, cancer, diabetes or crd between exact ages 30 and, Brazil or Greece?
- Brazil, at 17.3% against 16.4% in Greece as of 2021.
- What is the difference in mortality from cvd, cancer, diabetes or crd between exact ages 30 and between Brazil and Greece?
- 0.9%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Greece?
- 22 years are reported by both, from 2000 to 2021.
- How do Brazil and Greece rank globally for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
- Brazil ranks 124th and Greece ranks 127th of 185 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).